BioAtla, Inc.

NASDAQ:BCAB

0.4298 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -69.776-123.462-106.482-95.402-35.853-29.855-28.979
Depreciation & Amortization 0.9251.2211.1991.331.0080.860.794
Deferred Income Tax 000-0.6864.4640.0060
Stock Based Compensation 8.92113.54414.56325.1173.022-0.0060.003
Change In Working Capital -11.1994.680.2877.424-2.49825.102-9.704
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -13.4615.28407.992-1.663.130.446
Other Working Capital 2.262-0.6040.287-0.568-0.83821.972-10.15
Other Non Cash Items -0.8070.0020.0130.003-6.477-5.7522.572
Operating Cash Flow -71.936-104.015-90.42-62.214-36.334-9.645-35.317
Investing Activities:
Investments In Property Plant And Equipment 0-0.098-0.268-0.924-0.59-1.509-0.988
Acquisitions Net 000.0030-0.019-0.0050.019
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 000-0.9240.0190.0050
Investing Cash Flow 0-0.098-0.265-0.924-0.59-1.509-0.988
Financing Activities:
Debt Repayment 00003.43245
Common Stock Issued 9.2150.33661.68270.994200.22900
Common Stock Repurchased 0-000000
Dividends Paid 0000000
Other Financing Activities 0.2960.077-0.469-1.48268.164-0.0050.019
Financing Cash Flow 9.5110.0770.06169.512271.8253.9955.019
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -62.425-104.036-29.4726.374234.901-7.159-31.286
Cash At End Of Period 49.046111.471215.507244.979238.6053.70410.863